Drug Database
Back to search

Netherlands· NL-97604628bd7a

Lutathera 370 MBq/ml, oplossing voor infusie

A lutetium (177lu) oxodotreotide product containing lutetium (177lu) oxodotreotide, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.

ATC V10XX04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLutathera 370 MBq/ml, oplossing voor …ATCV10XX04REGISTER NO.NL-97604628bd7aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lutetium (177lu) oxodotreotideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lutetium (177lu) oxodotreotide is registered in 11 of 19 countries.

Countries holding a registration under ATC V10XX04 (lutetium (177lu) oxodotreotide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search lutetium (177lu) oxodotreotide products by name

Lutetium (177lu) oxodotreotide · ATC V10XX04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LUTETIUM (177LU) OXODOTREOTIDE
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
V10XX04
ATC class
Lutetium (177Lu) oxodotreotide
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1226

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lutetium (177lu) oxodotreotide in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lutetium (177lu) oxodotreotide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Lutathera
  • Liechtenstein · Lutathera
  • Norway · Lutathera

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e46038b9-57a1-4f09-9910-0478edc911ed
GET /v1/drugs/e46038b9-57a1-4f09-9910-0478edc911ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/lutathera-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Lutetium(177 Lu)oxodotreotide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp119314",
  "excipients": [
    "ASCORBINEZUUR (E 300)",
    "AZIJNZUUR (E 260)",
    "GENTISINEZUUR",
    "NATRIUMACETAAT 0-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "PENTETINEZUUR",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "LUTETIUM (177LU) OXODOTREOTIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2017/09/26",
  "procedure_number": "EMEA/H/C/004123",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1226",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about lutetium (177lu) oxodotreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console